February 28, 2011

CAS databases provide millions of journal article references from more than 10,000 major scientific journals worldwide, patent and patent family references from 61 patent authorities around the world, and other reputable web sources.

The following patent record is from the CAplusSM database.


Patent Number: US 7875729
Title: Process for preparation of trans-asenapine employing stereoselective hydrogenation of a dibenzoxepine intermediate
Inventor(s): Zhu, Jie; Keltjens, Rolf; Firet, Judith Janneke
Patent Assignee(s): Synthon B.V., Neth.
Source: PCT Int. Appl., 29pp. CODEN: PIXXD
Language: English
Asenapine and related trans-isomer bicyclic compds. can be obtained by reducing a compound of Formula (C) to preferentially form a trans-isomer compound of Formula (D), followed by subsequent ring closure to form a   compound of Formula (B) such as asenapine.  A method for preparing asenapine (I), and related trans-isomer bicyclic compds., is disclosed.  The  stereoselectivity arises via the hydrogenation of a dibenzoxepine    dicarboxylate intermediate II (R1 and R2 independently = alkyl, alkynyl or aralkyl group).  The reduction product of II (R1 and R2 = Me) then undergoes heterocyclization with methylamine to provide the desired I.


View the full-text patent from USPTO.

Recent News

    August 21, 2016 | CAS announces SciFindern, a new
    research experience that elevates scientific discovery

    August 19, 2016 | CAS seeks to help undergraduate
    students think like researchers with Chemistry
    Class Advantage, an organic chemistry learning
    solution powered by SciFinder

    August 1, 2016 | CAS Strengthens its Commitment to
    Science and Innovation Selecting 26 Outstanding
    International Scientists to Participate in the 2016
    SciFinder Future Leaders Program

                                                                       More News >> 

 Media Contact

 Name: Rhonda Ross
 Phone: 614-447-3624                                       
 Email: cas-pr@cas.org